article thumbnail

The Most Engaging Decision You’ll Read All Year – Five Stars

FDA Law Blog

Let’s just say, the smackdown—er, decision—eviscerates FDA’s approach to regulating flavored e-cigarettes. FDA complied with that order, later extended the deadline because of COVID, and eventually settled on a PMTA deadline of September 9, 2020. In Wages and White Lion Investments (DBA Triton Distribution) v.

article thumbnail

RCT of PC in ED: Corita Grudzen, Fernanda Bellolio, & Tammie Quest

GeriPal

You know, most, most ERs admit, you know, far fewer than 50% of their patients. They go to observation and go home or just get discharged straight from the ER? Yeah, that’s a more complicated story. But yeah, it’s complicated. So I’m going to be called every 20 minutes to go to the ER.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Ding Dong is the Skinny Label (Effectively) Dead?

FDA Law Blog

Teva submitted an ANDA in 2002, and after some complicated regulatory history, ultimately carved-out the congestive heart failure indication by way of a section viii statement. Teva argued that the October 2020 decision, due in part to a lack of clarity, essentially imposed liability on any ANDA filer relying on a carve-out.

IT 52
article thumbnail

Hospital-at-Home: Bruce Leff and Tacara Soones

GeriPal

2020 Hospital at Home-Plus: A Platform of Facility-Based Care. The pneumonia could get treated, but I think geriatricians, actually, were well aware of iatrogenic complications of care and quality gaps, even well before the IOM reports of the late 1990s and the like. That started in November of 2020. Annals of Int Med.

Hospital 115